Trade Summary

6 days ago, Klinger Shannon Thyme, serving as Chief Legal Officer at Moderna, Inc. (MRNA), sold 3,471 shares at $50.00 per share, for a total transaction value of $173,550.00. Following this transaction, Klinger Shannon Thyme now holds 67,468 shares of MRNA.

This sale represents a 4.89% decrease in Klinger Shannon Thyme's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, June 4, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 8, 2026 at 4:34 PM ET, 4 days after the trade was made.

Moderna, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.